Vertex Pharmaceuticals is diversifying from its cystic fibrosis dominance into pain and other markets. Check out our ...

Vertex Pharmaceuticals (VRTX) announced that the European Commission has granted regulatory approval for a label expansion of KAFTRIO in a combination regimen with ivacaftor for the treatment of ...

The median forecasts in this calendar come from surveys of economists conducted by Dow Jones Newswires and The Wall Street Journal. All statistics in this calendar are in expressed in nominal ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Three people with type 1 diabetes who received Vertex Pharma’s islet cell therapy VX-880 have been able to come off insulin altogether within a year, raising the prospect of a life without ...

The dish has long been a home-cooked staple in the Rio Grande Valley, but it's started popping up on restaurant menus all over Texas.

Vertex42 specializes in Excel-based calendars, perfect for those who need editable formats. Their calendars feature customizable fields and are particularly suited for business planning and project ...